FindTrial
Sign In

Medication-Related Issues in Ovarian Cancer Patients

Development of Evidence-based Indicators for the Detection of Drug-Related Problems and their Pharmacoeconomic Impact on Ovarian Cancer Patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/08/035818
Enrollment
143
Registered
2021-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Hospitalized patients above 18 years of age Diagnosed with ovarian cancer and receiving chemotherapy and willing to participate in the study

Exclusion criteria

Exclusion criteria: Patients who are having psychiatric and other terminal illnesses Pregnant and breastfeeding patients Patients diagnosed with more than two primary cancer Patients having other severe comorbidities like; Uncontrolled DM, uncontrolled HTN, and other severe cardiac co-morbidities.

Design outcomes

Primary

MeasureTime frame
Development of the prediction model for the detection of DRPsTimepoint: The predictors will be developed with in the 12 to 18 months—

Secondary

MeasureTime frame
Clinical Outcomes and Economic outcomes after months Health-Related Quality of life Timepoint: The patients will be in follow-up from the day of hospital admission to discharge day.—

Countries

India

Contacts

Public ContactDr Uday Venkat Mateti

K.S. Hegde Medical Academy, Justice K. S. Hegde Charitable Hospital

drvijithshetty@gmail.com8861796017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026